Effect of cubebin against streptozotocin-induced diabetic nephropathy rats via inhibition TNF-α/NF-κB/TGF-β: in vivo and in silico study

Abstract Cubebin, a dibenzyl butyrolactone lignan belonging to several distinct families, including Aristolochiaceae, Myristicaceae, Piperaceae, and Rutaceae, and possesses several pharmacological activities, including analgesic, anti-inflammatory, antioxidant, and vasodilatory. The current study ai...

Full description

Saved in:
Bibliographic Details
Main Authors: Rahamat Unissa Syed, Sivakumar S. Moni, Weiam Hussein, Taghreed Mohammad Saad Alhaidan, Sondos Mohammed Y. Abumilha, Lama Khalid Alnahdi, Ling Shing Wong, Vetriselvan Subramaniyan, Vinoth Kumarasamy
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-87319-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862330908213248
author Rahamat Unissa Syed
Sivakumar S. Moni
Weiam Hussein
Taghreed Mohammad Saad Alhaidan
Sondos Mohammed Y. Abumilha
Lama Khalid Alnahdi
Ling Shing Wong
Vetriselvan Subramaniyan
Vinoth Kumarasamy
author_facet Rahamat Unissa Syed
Sivakumar S. Moni
Weiam Hussein
Taghreed Mohammad Saad Alhaidan
Sondos Mohammed Y. Abumilha
Lama Khalid Alnahdi
Ling Shing Wong
Vetriselvan Subramaniyan
Vinoth Kumarasamy
author_sort Rahamat Unissa Syed
collection DOAJ
description Abstract Cubebin, a dibenzyl butyrolactone lignan belonging to several distinct families, including Aristolochiaceae, Myristicaceae, Piperaceae, and Rutaceae, and possesses several pharmacological activities, including analgesic, anti-inflammatory, antioxidant, and vasodilatory. The current study aimed to evaluate the effect of cubebin on streptozotocin (STZ)-evoked diabetic nephropathy (DN). DN is a well-identified complication of diabetes mellitus (DM) characterized by renal hypertrophy that progressively declines kidney function. Wistar rats were randomly divided into groups- normal, STZ control (65 mg/kg/body weight), and STZ + cubebin (10 and 20 mg/kg). Biochemical parameters such as glucose levels, kidney parameters, lipid profile, oxidative stress, endogenous antioxidant markers, inflammatory cytokines and histopathology were performed. Molecular docking [(PDB ID: TNF-α (7JRA), NF-κB (1SVC), TGF-β1 (3TZM)] and dynamic simulation (MDS) were also performed with the selected target. STZ-induced DN was changes in these parameters. In contrast, DN + cubebin at 10 and 20 mg/kg doses improved the biochemical parameters and histological changes. Furthermore, molecular docking and simulation studies showed a binding affinity with negative binding energy with TNF-α (7jra, − 11.342 kcal/mol), TGF-β1 (3tzm, − 9.162 kcal/mol) and NF-κB (1svc, − 6.665 kcal/mol). The results of MDS provided insight into the mechanisms that associate proteins TNF-α, NF-κB, and TGF-β1 in conformational dynamics upon binding to cubebin. In conclusion, these findings exhibit a potential effect of cubebin in STZ-evoked DN rats.
format Article
id doaj-art-b0732e2b3aef4483a0d5245c1879438a
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-b0732e2b3aef4483a0d5245c1879438a2025-02-09T12:33:16ZengNature PortfolioScientific Reports2045-23222025-02-0115112610.1038/s41598-025-87319-7Effect of cubebin against streptozotocin-induced diabetic nephropathy rats via inhibition TNF-α/NF-κB/TGF-β: in vivo and in silico studyRahamat Unissa Syed0Sivakumar S. Moni1Weiam Hussein2Taghreed Mohammad Saad Alhaidan3Sondos Mohammed Y. Abumilha4Lama Khalid Alnahdi5Ling Shing Wong6Vetriselvan Subramaniyan7Vinoth Kumarasamy8Department of Pharmaceutics, College of Pharmacy, University of Ha’ilDepartment of Pharmaceutics, College of Pharmacy, Jazan UniversityDepartment of Pharmaceutical Chemistry, College of Pharmacy, University of HailDepartment of Clinical Toxicology, College of Medicine, Umm Al-Qura UniversityCollege of Medicine, King Khalid UniversityCollege of Medicine, King Khalid UniversityFaculty of Health and Life Sciences, INTI International UniversityDivision of Pharmacology, School of Medical and Life Sciences, Sunway UniversityDepartment of Parasitology and Medical Entomology, Faculty of Medicine, Universiti Kebangsaan MalaysiaAbstract Cubebin, a dibenzyl butyrolactone lignan belonging to several distinct families, including Aristolochiaceae, Myristicaceae, Piperaceae, and Rutaceae, and possesses several pharmacological activities, including analgesic, anti-inflammatory, antioxidant, and vasodilatory. The current study aimed to evaluate the effect of cubebin on streptozotocin (STZ)-evoked diabetic nephropathy (DN). DN is a well-identified complication of diabetes mellitus (DM) characterized by renal hypertrophy that progressively declines kidney function. Wistar rats were randomly divided into groups- normal, STZ control (65 mg/kg/body weight), and STZ + cubebin (10 and 20 mg/kg). Biochemical parameters such as glucose levels, kidney parameters, lipid profile, oxidative stress, endogenous antioxidant markers, inflammatory cytokines and histopathology were performed. Molecular docking [(PDB ID: TNF-α (7JRA), NF-κB (1SVC), TGF-β1 (3TZM)] and dynamic simulation (MDS) were also performed with the selected target. STZ-induced DN was changes in these parameters. In contrast, DN + cubebin at 10 and 20 mg/kg doses improved the biochemical parameters and histological changes. Furthermore, molecular docking and simulation studies showed a binding affinity with negative binding energy with TNF-α (7jra, − 11.342 kcal/mol), TGF-β1 (3tzm, − 9.162 kcal/mol) and NF-κB (1svc, − 6.665 kcal/mol). The results of MDS provided insight into the mechanisms that associate proteins TNF-α, NF-κB, and TGF-β1 in conformational dynamics upon binding to cubebin. In conclusion, these findings exhibit a potential effect of cubebin in STZ-evoked DN rats.https://doi.org/10.1038/s41598-025-87319-7AntioxidantCubebinDiabetic nephropathyStreptozotocinDiabetes
spellingShingle Rahamat Unissa Syed
Sivakumar S. Moni
Weiam Hussein
Taghreed Mohammad Saad Alhaidan
Sondos Mohammed Y. Abumilha
Lama Khalid Alnahdi
Ling Shing Wong
Vetriselvan Subramaniyan
Vinoth Kumarasamy
Effect of cubebin against streptozotocin-induced diabetic nephropathy rats via inhibition TNF-α/NF-κB/TGF-β: in vivo and in silico study
Scientific Reports
Antioxidant
Cubebin
Diabetic nephropathy
Streptozotocin
Diabetes
title Effect of cubebin against streptozotocin-induced diabetic nephropathy rats via inhibition TNF-α/NF-κB/TGF-β: in vivo and in silico study
title_full Effect of cubebin against streptozotocin-induced diabetic nephropathy rats via inhibition TNF-α/NF-κB/TGF-β: in vivo and in silico study
title_fullStr Effect of cubebin against streptozotocin-induced diabetic nephropathy rats via inhibition TNF-α/NF-κB/TGF-β: in vivo and in silico study
title_full_unstemmed Effect of cubebin against streptozotocin-induced diabetic nephropathy rats via inhibition TNF-α/NF-κB/TGF-β: in vivo and in silico study
title_short Effect of cubebin against streptozotocin-induced diabetic nephropathy rats via inhibition TNF-α/NF-κB/TGF-β: in vivo and in silico study
title_sort effect of cubebin against streptozotocin induced diabetic nephropathy rats via inhibition tnf α nf κb tgf β in vivo and in silico study
topic Antioxidant
Cubebin
Diabetic nephropathy
Streptozotocin
Diabetes
url https://doi.org/10.1038/s41598-025-87319-7
work_keys_str_mv AT rahamatunissasyed effectofcubebinagainststreptozotocininduceddiabeticnephropathyratsviainhibitiontnfanfkbtgfbinvivoandinsilicostudy
AT sivakumarsmoni effectofcubebinagainststreptozotocininduceddiabeticnephropathyratsviainhibitiontnfanfkbtgfbinvivoandinsilicostudy
AT weiamhussein effectofcubebinagainststreptozotocininduceddiabeticnephropathyratsviainhibitiontnfanfkbtgfbinvivoandinsilicostudy
AT taghreedmohammadsaadalhaidan effectofcubebinagainststreptozotocininduceddiabeticnephropathyratsviainhibitiontnfanfkbtgfbinvivoandinsilicostudy
AT sondosmohammedyabumilha effectofcubebinagainststreptozotocininduceddiabeticnephropathyratsviainhibitiontnfanfkbtgfbinvivoandinsilicostudy
AT lamakhalidalnahdi effectofcubebinagainststreptozotocininduceddiabeticnephropathyratsviainhibitiontnfanfkbtgfbinvivoandinsilicostudy
AT lingshingwong effectofcubebinagainststreptozotocininduceddiabeticnephropathyratsviainhibitiontnfanfkbtgfbinvivoandinsilicostudy
AT vetriselvansubramaniyan effectofcubebinagainststreptozotocininduceddiabeticnephropathyratsviainhibitiontnfanfkbtgfbinvivoandinsilicostudy
AT vinothkumarasamy effectofcubebinagainststreptozotocininduceddiabeticnephropathyratsviainhibitiontnfanfkbtgfbinvivoandinsilicostudy